In vitro prototyping and rapid optimization of biosynthetic enzymes for cell design

The design and optimization of biosynthetic pathways for industrially relevant, non-model organisms is challenging due to transformation idiosyncrasies, reduced numbers of validated genetic parts and a lack of high-throughput workflows. Here we describe a platform for in vitro prototyping and rapid optimization of biosynthetic enzymes (iPROBE) to accelerate this process. In iPROBE, cell lysates are enriched with biosynthetic enzymes by cell-free protein synthesis and then metabolic pathways are assembled in a mix-and-match fashion to assess pathway performance. We demonstrate iPROBE by screening 54 different cell-free pathways for 3-hydroxybutyrate production and optimizing a six-step butanol pathway across 205 permutations using data-driven design. Observing a strong correlation ( r  = 0.79) between cell-free and cellular performance, we then scaled up our highest-performing pathway, which improved in vivo 3-HB production in Clostridium by 20-fold to 14.63 ± 0.48 g l −1 . We expect iPROBE to accelerate design–build–test cycles for industrial biotechnology. The iPROBE platform accelerates the design and optimization of engineered biosynthetic pathways using a combination of cell-free protein synthesis, in vitro pathway assembly and a scoring system to identify high-performing combinations.

[1]  James M. Clomburg,et al.  Industrial biomanufacturing: The future of chemical production , 2017, Science.

[2]  Michael C. Jewett,et al.  High-throughput preparation methods of crude extract for robust cell-free protein synthesis , 2015, Scientific Reports.

[3]  Functional Screening and In Vitro Analysis Reveal Thioesterases with Enhanced Substrate Specificity Profiles That Improve Short-Chain Fatty Acid Production in Escherichia coli , 2013, Applied and Environmental Microbiology.

[4]  Ngoc-Phuong-Thao Nguyen,et al.  Reviving the Weizmann process for commercial n-butanol production , 2018, Nature Communications.

[5]  Guoqiang Chen,et al.  Enhanced production of D-(-)-3-hydroxybutyric acid by recombinant Escherichia coli. , 2002, FEMS microbiology letters.

[6]  Christoph Hold,et al.  Forward design of a complex enzyme cascade reaction , 2016, Nature Communications.

[7]  Michael C Jewett,et al.  An integrated cell-free metabolic platform for protein production and synthetic biology , 2008, Molecular systems biology.

[8]  Darrell Whitley,et al.  A genetic algorithm tutorial , 1994, Statistics and Computing.

[9]  J. Heap,et al.  A modular system for Clostridium shuttle plasmids. , 2009, Journal of microbiological methods.

[10]  M. Jewett,et al.  Mimicking the Escherichia coli cytoplasmic environment activates long‐lived and efficient cell‐free protein synthesis , 2004, Biotechnology and bioengineering.

[11]  M. Inui,et al.  Expression of Clostridium acetobutylicum butanol synthetic genes in Escherichia coli , 2008, Applied Microbiology and Biotechnology.

[12]  J. Liao,et al.  Synthetic non-oxidative glycolysis enables complete carbon conservation , 2013, Nature.

[13]  Ashty S Karim,et al.  Cell-Free Synthetic Biology for Pathway Prototyping. , 2018, Methods in enzymology.

[14]  K. Prather,et al.  Metabolic Engineering of Escherichia coli for Enhanced Production of (R)- and (S)-3-Hydroxybutyrate , 2009, Applied and Environmental Microbiology.

[15]  Devin H. Currie,et al.  Rediverting carbon flux in Clostridium ljungdahlii using CRISPR interference (CRISPRi). , 2018, Metabolic engineering.

[16]  K. Kim,et al.  Production of (S)-3-hydroxybutyrate by metabolically engineered Saccharomyces cerevisiae. , 2015, Journal of biotechnology.

[17]  K. Winzer,et al.  Metabolic engineering of Clostridium autoethanogenum for selective alcohol production , 2017, Metabolic engineering.

[18]  J. Liao,et al.  Driving Forces Enable High-Titer Anaerobic 1-Butanol Synthesis in Escherichia coli , 2011, Applied and Environmental Microbiology.

[19]  E. Papoutsakis,et al.  Clostridia: the importance of their exceptional substrate and metabolite diversity for biofuel and biorefinery applications. , 2012, Current opinion in biotechnology.

[20]  비요른 다니엘 헤이스트라,et al.  Novel bacteria and methods of use thereof , 2011 .

[21]  L. T. Angenent,et al.  Biocatalytic reduction of short‐chain carboxylic acids into their corresponding alcohols with syngas fermentation , 2013, Biotechnology and bioengineering.

[22]  D. T. Jones,et al.  Acetone-butanol fermentation revisited. , 1986, Microbiological reviews.

[23]  B. Heijstra,et al.  Gas Fermentation—A Flexible Platform for Commercial Scale Production of Low-Carbon-Fuels and Chemicals from Waste and Renewable Feedstocks , 2016, Front. Microbiol..

[24]  J. Keasling,et al.  Engineering Cellular Metabolism , 2016, Cell.

[25]  Douglas C. Friedman.  Industrialization of Biology. A Roadmap to Accelerate the Advanced Manufacturing of Chemicals , 2015 .

[26]  P. Dürre,et al.  Anaerobic Production of Poly(3-hydroxybutyrate) and Its Precursor 3-Hydroxybutyrate from Synthesis Gas by Autotrophic Clostridia. , 2019, Biomacromolecules.

[27]  Simon Haykin,et al.  Neural Networks: A Comprehensive Foundation , 1998 .

[28]  Ashty S. Karim,et al.  Cell-free styrene biosynthesis at high titers , 2020, bioRxiv.

[29]  T. Roberts,et al.  Synthetic Biology for Cell-Free Biosynthesis: Fundamentals of Designing Novel In Vitro Multi-Enzyme Reaction Networks. , 2018, Advances in biochemical engineering/biotechnology.

[30]  Fuli Li,et al.  Coupled Ferredoxin and Crotonyl Coenzyme A (CoA) Reduction with NADH Catalyzed by the Butyryl-CoA Dehydrogenase/Etf Complex from Clostridium kluyveri , 2007, Journal of bacteriology.

[31]  P. Dürre,et al.  Clostridium ljungdahlii represents a microbial production platform based on syngas , 2010, Proceedings of the National Academy of Sciences.

[32]  Kevin M. Smith,et al.  Metabolic engineering of Escherichia coli for 1-butanol production. , 2008, Metabolic engineering.

[33]  D. R. Woods,et al.  Acetone-butanol fermentation revisited , 1986 .

[34]  Ralf Takors,et al.  Using gas mixtures of CO, CO2 and H2 as microbial substrates: the do's and don'ts of successful technology transfer from laboratory to production scale , 2018, Microbial biotechnology.

[35]  R. Mahadevan,et al.  Engineering a short, aldolase-based pathway for (R)-1,3-butanediol production in Escherichia coli. , 2018, Metabolic engineering.

[36]  Ka-Yiu San,et al.  Improvement of butanol production in Clostridium acetobutylicum through enhancement of NAD(P)H availability , 2018, Journal of Industrial Microbiology & Biotechnology.

[37]  John A. Nelder,et al.  A Simplex Method for Function Minimization , 1965, Comput. J..

[38]  Adam D. Silverman,et al.  Cell-free gene expression: an expanded repertoire of applications , 2019, Nature Reviews Genetics.

[39]  B. Heijstra,et al.  Maintenance of ATP Homeostasis Triggers Metabolic Shifts in Gas-Fermenting Acetogens. , 2017, Cell systems.

[40]  Michael C Jewett,et al.  Cell-Free Mixing of Escherichia coli Crude Extracts to Prototype and Rationally Engineer High-Titer Mevalonate Synthesis. , 2016, ACS synthetic biology.

[41]  E. Green.  Fermentative production of butanol--the industrial perspective. , 2011, Current opinion in biotechnology.

[42]  E. Papoutsakis,et al.  Engineering Clostridium organisms as microbial cell-factories: challenges & opportunities. , 2018, Metabolic engineering.

[43]  Michael C Jewett,et al.  Lysate of engineered Escherichia coli supports high-level conversion of glucose to 2,3-butanediol. , 2015, Metabolic engineering.

[44]  Michael C Jewett,et al.  Cell-free biosynthesis of limonene using enzyme-enriched Escherichia coli lysates , 2019, Synthetic biology.

[45]  M. Jewett,et al.  Substrate replenishment extends protein synthesis with an in vitro translation system designed to mimic the cytoplasm , 2004, Biotechnology and bioengineering.

[46]  Ashty S Karim,et al.  A cell-free framework for rapid biosynthetic pathway prototyping and enzyme discovery. , 2016, Metabolic engineering.

[47]  T. Tajima,et al.  Enhancement of (R)-1,3-butanediol production by engineered Escherichia coli using a bioreactor system with strict regulation of overall oxygen transfer coefficient and pH , 2014, Bioscience, biotechnology, and biochemistry.

[48]  Ashty S. Karim,et al.  Cell‐free metabolic engineering: Biomanufacturing beyond the cell , 2015, Biotechnology journal.

[49]  Richard J. R. Kelwick,et al.  Cell-free prototyping strategies for enhancing the sustainable production of polyhydroxyalkanoates bioplastics , 2017, bioRxiv.

[50]  Michael Köpke,et al.  2,3-Butanediol Production by Acetogenic Bacteria, an Alternative Route to Chemical Synthesis, Using Industrial Waste Gas , 2011, Applied and Environmental Microbiology.

[51]  Ashty S. Karim,et al.  Controlling cell-free metabolism through physiochemical perturbations. , 2018, Metabolic engineering.

[52]  Martin Fussenegger,et al.  Engineering synergy in biotechnology. , 2014, Nature chemical biology.

[53]  Tiangang Liu,et al.  In vitro reconstitution of mevalonate pathway and targeted engineering of farnesene overproduction in Escherichia coli , 2014, Biotechnology and bioengineering.

[54]  W. Buckel,et al.  Reduction of ferredoxin or oxygen by flavin‐based electron bifurcation in Megasphaera elsdenii , 2015, The FEBS Journal.

[55]  M. Pera‐Titus,et al.  Direct dehydration of 1,3-butanediol into butadiene over aluminosilicate catalysts , 2016 .

[56]  Michael Köpke,et al.  Genome editing of Clostridium autoethanogenum using CRISPR/Cas9 , 2016, Biotechnology for Biofuels.